1. Fatigue associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis

   • Jing Li
   • Jian Gu

   Review Article 21 July 2017 Pages: 807 - 816

   

2. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis

   • Xingxing Tang
   • Peng Du
   • Yong Yang

   Review Article 27 July 2017 Pages: 817 - 825

   

3. Current status of superficial pharyngeal squamous cell carcinoma in Japan

   • Ryoko Rikitake
   • Mizuo Ando
   • Takahiro Higashi

   Original Article 13 May 2017 Pages: 826 - 833

   

4. Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience

   • Juan Liu
   • Huapeng Yu
   • Allison Fry

   Original Article 10 June 2017 Pages: 834 - 842

   

5. The rate of facial nerve dysfunction and time to recovery after intraparotid and extraparotid facial nerve exposure and protection in head and neck cutaneous tumor surgery

   • Yasuhiro Nakamura
   • Yukiko Teramoto
   • Akifumi Yamamoto

   Original Article 09 June 2017 Pages: 843 - 848

   

6. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)

   • Tomoki Kimura
   • Yasushi Nagata
   • Takeshi Ehara

   Original Article 02 May 2017 Pages: 849 - 856

   

7. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy

   • Teruhisa Takuwa
   • Masaki Hashimoto
   • Seiki Hasegawa

   Original Article 24 April 2017 Pages: 857 - 864

   

8. Diagnostic accuracy of computed tomography imaging for the detection of differences between peripheral small cell lung cancer and peripheral non-small cell lung cancer

   • Yanchen Ren
   • Yiyuan Cao
   • Xiaoyan Shen

   Original Article Open access 09 May 2017 Pages: 865 - 871

   

9. High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma

   • Yosuke Miura
   • Kyoichi Kaira
   • Masanobu Yamada

   Original Article 26 May 2017 Pages: 872 - 879

   

10. Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety

    • Ikuko Sugitani
    • Shigeto Ueda
    • Toshiaki Saeki

    Original Article Open access 25 May 2017 Pages: 880 - 886

    

11. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy

    • Kazuki Kano
    • Toru Aoyama
    • Takaki Yoshikawa

    Original Article 29 April 2017 Pages: 887 - 896

    

12. Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence

    • Takuma Ohashi
    • Shuhei Komatsu
    • Eigo Otsuji

    Original Article 09 May 2017 Pages: 897 - 904

    

13. A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma

    • Takahiro Horimatsu
    • Norisuke Nakayama
    • Manabu Muto

    Original Article Open access 23 May 2017 Pages: 905 - 912

    

14. A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)

    • Koji Ando
    • Yasunori Emi
    • Kyushu Study Group of Clinical Cancer (KSCC)

    Original Article 19 May 2017 Pages: 913 - 920

    

15. Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

    • Yusuke Tanaka
    • Yutaka Ueda
    • Tadashi Kimura

    Original Article 27 April 2017 Pages: 921 - 926

    

16. The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience

    • Seiji Mabuchi
    • Yuri Matsumoto
    • Tadashi Kimura

    Original Article 27 May 2017 Pages: 927 - 936

    

17. Risk factors for paraaortic lymph node metastasis in endometrial cancer

    • Mustafa Erkan Sari
    • İbrahim Yalcin
    • Tayfun Gungor

    Original Article 18 May 2017 Pages: 937 - 944

18. Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?

    • A. Smits
    • J. McGrane
    • K. Galaal

    Original Article 15 June 2017 Pages: 945 - 953

    

19. Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

    • Hiroji Uemura
    • Hirotsugu Uemura
    • Toshihiko Doi

    Original Article Open access 06 May 2017 Pages: 954 - 963

    

20. A critical prognostic analysis of neutrophil–lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma

    • Mesut Altan
    • Hakan Bahadır Haberal
    • Haluk Özen

    Original Article 09 June 2017 Pages: 964 - 971

21. Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy

    • Masayuki Shiseki
    • Chikashi Yoshida
    • Koiti Inokuchi

    Original Article Open access 26 May 2017 Pages: 972 - 979

    

22. Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bone cancer pain: a randomized controlled trial

    • Zunyong Liu
    • Yan Xu
    • Xiao-heng Shen

    Original Article 08 May 2017 Pages: 980 - 985

    

23. Erratum to: Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy

    • Takaaki Higashi
    • Hiromitsu Hayashi
    • Hideo Baba

    Erratum 28 July 2017 Pages: 986 - 990